Pub. Date : 2021 Aug
PMID : 32964398
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The increase in EGFR tyrosine phosphorylation caused by PACAP was blocked by the EGFR tyrosine kinase inhibitor (TKI) gefitinib, or PACAP(6-38), a PAC1 antagonist. | Tyrosine | adenylate cyclase activating polypeptide 1 | Homo sapiens |
| 2 | The increase in HER2 tyrosine phosphorylation caused by PACAP was inhibited by trastuzumab, a monoclonal antibody (mAb) for HER2, or PACAP(6-38). | Tyrosine | adenylate cyclase activating polypeptide 1 | Homo sapiens |
| 3 | The increase in HER2 tyrosine phosphorylation caused by PACAP was inhibited by trastuzumab, a monoclonal antibody (mAb) for HER2, or PACAP(6-38). | Tyrosine | adenylate cyclase activating polypeptide 1 | Homo sapiens |
| 4 | The increase in HER3 tyrosine phosphorylation caused by PACAP was inhibited by HER3 mAb3481 or PACAP(6-38). | Tyrosine | adenylate cyclase activating polypeptide 1 | Homo sapiens |
| 5 | The increase in HER3 tyrosine phosphorylation caused by PACAP was inhibited by HER3 mAb3481 or PACAP(6-38). | Tyrosine | adenylate cyclase activating polypeptide 1 | Homo sapiens |